Cargando…
Pleural Mesothelioma: Advances in Blood and Pleural Biomarkers
Pleural mesothelioma (PM) is a type of cancer that is highly related to exposure to asbestos fibers. It shows aggressive behavior, and the current therapeutic approaches are usually insufficient to change the poor prognosis. Moreover, apart from staging and histological classification, there are no...
Autores principales: | Sorino, Claudio, Mondoni, Michele, Marchetti, Giampietro, Agati, Sergio, Inchingolo, Riccardo, Mei, Federico, Flamini, Sara, Lococo, Filippo, Feller-Kopman, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672377/ https://www.ncbi.nlm.nih.gov/pubmed/38002620 http://dx.doi.org/10.3390/jcm12227006 |
Ejemplares similares
-
Malignant Pleural Mesothelioma: Time Is Running Out
por: Lococo, Filippo
Publicado: (2021) -
Oncological Frontiers in the Treatment of Malignant Pleural Mesothelioma
por: Vita, Emanuele, et al.
Publicado: (2021) -
The Evolving Landscape of the Molecular Epidemiology of Malignant Pleural Mesothelioma
por: Lettieri, Sara, et al.
Publicado: (2021) -
Circulating biomarkers in malignant pleural mesothelioma
por: Viscardi, Giuseppe, et al.
Publicado: (2020) -
The Evolving Role of Immune-Checkpoint Inhibitors in Malignant Pleural Mesothelioma
por: Borgeaud, Maxime, et al.
Publicado: (2023)